Thyroid Gland Disorders Treatment Market by Disease Type and Drug Type - Global Industry Analysis & Forecast to 2027
Published On : January 2020 Pages : 170 Category: Pharma & Healthcare Report Code : HC018210
Thyroid Gland Disorders Treatment Market By Disease Type (Hyperthyroidism and Hypothyroidism), Drug Type (Levothyroxine, Liothyronine, Propylthiouracil, Imidazole-based Compound, and Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Thyroid Gland Disorders Treatment Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Thyroid Gland Disorder Treatment Market is an endocrine organ that invigorates hormones, which help manage the digestion of the body. At the point when the thyroid organ doesn't deliver enough thyroid hormones (hypothyroidism) or an excess of hormone (hyperthyroidism), the digestion and working of the body is upset. The absence of iodine in the body is a central point that prompts thyroid issue.
Drivers and Restraints
The central point that drive the development of the market remember increment for the rate of thyroid organ issue, ascend in the quantity of sickness mindfulness programs particularly in the creating nations, and improvement of successful blend medicate treatments to treat thyroid organ issue. Be that as it may, symptoms of the medications and stringent government guidelines hamper the market development. Also, accessibility of enormous pool of undiscovered patients because of asymptomatic nature of thyroid issue help open new roads for the market development during the figure time frame.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- AbbVie Inc.
- Merck & Co., Inc.
- Allergan plc
- GlaxoSmithKline plc
- RLC LABS, Inc.
- Pfizer Inc.
- Lannett Company, Inc.
- Mylan N.V.
- Novartis AG
- Abbott Laboratories
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Thyroid Gland Disorders Treatment Market, By Disease Type, Estimates and Forecast, 2017-2027 ($Million)
o Hyperthyroidism
o Hypothyroidism
· Thyroid Gland Disorders Treatment Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Levothyroxine
o Liothyronine
o Propylthiouracil
o Imidazole-based Compound
o Others
· Thyroid Gland Disorders Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o AbbVie Inc.
o Merck & Co., Inc.
o Allergan plc
o GlaxoSmithKline plc
o RLC LABS, Inc.
o Pfizer Inc.
o Lannett Company, Inc.
o Mylan N.V.
o Novartis AG
o Abbott Laboratories
· Thyroid Gland Disorders Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Thyroid Gland Disorders Treatment Market, By Country
o U.S. Thyroid Gland Disorders Treatment Market
o Canada Thyroid Gland Disorders Treatment Market
o Mexico Thyroid Gland Disorders Treatment Market
o Europe
§ Europe Thyroid Gland Disorders Treatment Market, By Country
o Germany Thyroid Gland Disorders Treatment Market
o UK Thyroid Gland Disorders Treatment Market
o France Thyroid Gland Disorders Treatment Market
o Russia Thyroid Gland Disorders Treatment Market
o Italy Thyroid Gland Disorders Treatment Market
o Rest of Europe Thyroid Gland Disorders Treatment Market
o Asia-Pacific
§ Asia-Pacific Thyroid Gland Disorders Treatment Market, By Country
o China Thyroid Gland Disorders Treatment Market
o Japan Thyroid Gland Disorders Treatment Market
o South Korea Thyroid Gland Disorders Treatment Market
o India Thyroid Gland Disorders Treatment Market
o Southeast Asia Thyroid Gland Disorders Treatment Market
o Rest of Asia-Pacific Thyroid Gland Disorders Treatment Market
o South America
§ South America Thyroid Gland Disorders Treatment Market
o Brazil Thyroid Gland Disorders Treatment Market
o Argentina Thyroid Gland Disorders Treatment Market
o Columbia Thyroid Gland Disorders Treatment Market
o Rest of South America Thyroid Gland Disorders Treatment Market
o Middle East and Africa
§ Middle East and Africa Thyroid Gland Disorders Treatment Market
o Saudi Arabia Thyroid Gland Disorders Treatment Market
o UAE Thyroid Gland Disorders Treatment Market
o Egypt Thyroid Gland Disorders Treatment Market
o Nigeria Thyroid Gland Disorders Treatment Market
o South Africa Thyroid Gland Disorders Treatment Market
o Rest of MEA Thyroid Gland Disorders Treatment Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Thyroid Gland Disorders Treatment Market, By Disease Type
5.1. Introduction
5.2. Global Thyroid Gland Disorders Treatment Revenue and Market Share by Disease Type (2017-2027)
5.2.1. Global Thyroid Gland Disorders Treatment Revenue and Revenue Share by Disease Type (2017-2027)
5.3. Hyperthyroidism
5.3.1. Global Hyperthyroidism Revenue and Growth Rate (2017-2027)
5.4. Hypothyroidism
5.4.1. Global Hypothyroidism Revenue and Growth Rate (2017-2027)
6. Thyroid Gland Disorders Treatment Market, By Application
6.1. Introduction
6.2. Global Thyroid Gland Disorders Treatment Revenue and Market Share by Application (2017-2027)
6.2.1. Global Thyroid Gland Disorders Treatment Revenue and Revenue Share by Application (2017-2027)
6.3. Levothyroxine
6.3.1. Global Levothyroxine Revenue and Growth Rate (2017-2027)
6.4. Liothyronine
6.4.1. Global Liothyronine Revenue and Growth Rate (2017-2027)
6.5. Propylthiouracil
6.5.1. Global Propylthiouracil Revenue and Growth Rate (2017-2027)
6.6. Imidazole-based Compound
6.6.1. Global Imidazole-based Compound Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Thyroid Gland Disorders Treatment Market, By Region
7.1. Introduction
7.2. Global Thyroid Gland Disorders Treatment Revenue and Market Share by Regions
7.2.1. Global Thyroid Gland Disorders Treatment Revenue by Regions (2017-2027)
7.3. North America Thyroid Gland Disorders Treatment by Countries
7.3.1. North America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2027)
7.3.2. North America Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Thyroid Gland Disorders Treatment by Countries
7.4.1. Europe Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2027)
7.4.2. Europe Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Thyroid Gland Disorders Treatment by Countries
7.5.1. Asia-Pacific Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Thyroid Gland Disorders Treatment by Countries
7.6.1. South America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2027)
7.6.2. South America Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Thyroid Gland Disorders Treatment by Countries
7.7.1. Middle East and Africa Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. AbbVie Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Merck & Co., Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Allergan plc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. GlaxoSmithKline plc
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. RLC LABS, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Pfizer Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Lannett Company, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Mylan N.V.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Novartis AG
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Abbott Laboratories
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.1. Global Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Thyroid Gland Disorders Treatment Market Forecast by Regions (2017-2027)
9.2.1. North America Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.1.1. United States Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.1.2. Canada Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.1.3. Mexico Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2. Europe Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2.1. Germany Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2.2. France Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2.3. UK Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2.4. Russia Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2.5. Italy Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3. Asia-Pacific Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3.1. China Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3.2. Japan Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3.3. Korea Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3.4. India Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.4. South America Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.4.1. Brazil Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.4.2. Argentina Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.4.3. Columbia Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.4.4. Rest of South America Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5. Middle East and Africa Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.3. Egypt Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.4. Nigeria Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.5. South Africa Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.6. Turkey Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Thyroid Gland Disorders Treatment Market Forecast (2017-2027)
9.3. Thyroid Gland Disorders Treatment Market Forecast by Disease Type (2017-2027)
9.3.1. Thyroid Gland Disorders Treatment Forecast by Disease Type (2017-2027)
9.3.2. Thyroid Gland Disorders Treatment Market Share Forecast by Disease Type (2017-2027)
9.4. Thyroid Gland Disorders Treatment Market Forecast by Application (2017-2027)
9.4.1. Thyroid Gland Disorders Treatment Forecast by Application (2017-2027)
9.4.2. Thyroid Gland Disorders Treatment Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Thyroid Gland Disorders Treatment Revenue and Revenue Share by Disease Type (2017-2018)
Figure Global Hyperthyroidism Revenue and Growth Rate (2017-2018)
Figure Global Hypothyroidism Revenue and Growth Rate (2017-2018)
Table Global Thyroid Gland Disorders Treatment Revenue and Revenue Share by Application (2017-2018)
Figure Global Levothyroxine Revenue and Growth Rate (2017-2018)
Figure Global Liothyronine Revenue and Growth Rate (2017-2018)
Figure Global Propylthiouracil Revenue and Growth Rate (2017-2018)
Figure Global Imidazole-based Compound Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Thyroid Gland Disorders Treatment Revenue by Regions (2017-2018)
Figure North America Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure North America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2018)
Figure North America Thyroid Gland Disorders Treatment by Countries (2017-2018)
Figure North America Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure United States Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Canada Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Mexico Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Europe Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Thyroid Gland Disorders Treatment by Countries (2017-2018)
Figure Europe Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Germany Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure France Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure UK Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Russia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Italy Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Rest of Europe Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Thyroid Gland Disorders Treatment by Countries (2017-2018)
Figure Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure China Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Japan Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Korea Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure India Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Southeast Asia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure South America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2018)
Figure South America Thyroid Gland Disorders Treatment by Countries (2017-2018)
Figure South America Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Brazil Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Argentina Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Columbia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Rest of South America Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Thyroid Gland Disorders Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Thyroid Gland Disorders Treatment by Countries (2017-2018)
Figure Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Egypt Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Nigeria Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure South Africa Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Turkey Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Thyroid Gland Disorders Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table AbbVie Inc. Thyroid Gland Disorders Treatment Financial Overview
Table Merck & Co., Inc. Thyroid Gland Disorders Treatment Financial Overview
Table Allergan plc Thyroid Gland Disorders Treatment Financial Overview
Table GlaxoSmithKline plc Thyroid Gland Disorders Treatment Financial Overview
Table RLC LABS, Inc. Thyroid Gland Disorders Treatment Financial Overview
Table Pfizer Inc. Thyroid Gland Disorders Treatment Financial Overview
Table Lannett Company, Inc. Thyroid Gland Disorders Treatment Financial Overview
Table Mylan N.V. Thyroid Gland Disorders Treatment Financial Overview
Table Novartis AG Thyroid Gland Disorders Treatment Financial Overview
Table Abbott Laboratories Thyroid Gland Disorders Treatment Financial Overview
Figure Global Thyroid Gland Disorders Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Thyroid Gland Disorders Treatment Market Forecast by Regions (2018-2025)
Figure North America Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure United States Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Canada Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Mexico Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Europe Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Germany Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure France Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure UK Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Russia Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Italy Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Rest of Europe Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure China Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Japan Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Korea Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure India Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Southeast Asia Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure South America Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Brazil Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Argentina Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Columbia Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Rest of South America Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Egypt Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Nigeria Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure South Africa Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Turkey Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Thyroid Gland Disorders Treatment Market Forecast (2018-2025)
Figure Global Thyroid Gland Disorders Treatment Forecast by Disease Type (2018-2025)
Figure Global Thyroid Gland Disorders Treatment Market Share Forecast by Disease Type (2018-2025)
Figure Global Thyroid Gland Disorders Treatment Forecast by Disease Type (2018-2025)
Figure Global Thyroid Gland Disorders Treatment Forecast by Application (2018-2025)
Figure Global Thyroid Gland Disorders Treatment Market Share Forecast by Application (2018-2025)
Figure Global Thyroid Gland Disorders Treatment Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|